439 related articles for article (PubMed ID: 14707067)
21. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.
Metelitsa LS; Weinberg KI; Emanuel PD; Seeger RC
Leukemia; 2003 Jun; 17(6):1068-77. PubMed ID: 12764370
[TBL] [Abstract][Full Text] [Related]
22. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
[TBL] [Abstract][Full Text] [Related]
23. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
Maeda M; Shadeo A; MacFadyen AM; Takei F
J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
[TBL] [Abstract][Full Text] [Related]
24. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.
Gumperz JE; Miyake S; Yamamura T; Brenner MB
J Exp Med; 2002 Mar; 195(5):625-36. PubMed ID: 11877485
[TBL] [Abstract][Full Text] [Related]
25. Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells.
Takahashi T; Nieda M; Koezuka Y; Nicol A; Porcelli SA; Ishikawa Y; Tadokoro K; Hirai H; Juji T
J Immunol; 2000 May; 164(9):4458-64. PubMed ID: 10779745
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
27. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
28. Distinct functional lineages of human V(alpha)24 natural killer T cells.
Lee PT; Benlagha K; Teyton L; Bendelac A
J Exp Med; 2002 Mar; 195(5):637-41. PubMed ID: 11877486
[TBL] [Abstract][Full Text] [Related]
29. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
30. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes.
Leite-de-Moraes MC; Herbelin A; Gouarin C; Koezuka Y; Schneider E; Dy M
J Immunol; 2000 Oct; 165(8):4367-71. PubMed ID: 11035073
[TBL] [Abstract][Full Text] [Related]
31. Regulation of immune responses by CD1d-restricted natural killer T cells.
Van Kaer L
Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
[TBL] [Abstract][Full Text] [Related]
32. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
[TBL] [Abstract][Full Text] [Related]
33. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers.
Benlagha K; Weiss A; Beavis A; Teyton L; Bendelac A
J Exp Med; 2000 Jun; 191(11):1895-903. PubMed ID: 10839805
[TBL] [Abstract][Full Text] [Related]
34. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
[TBL] [Abstract][Full Text] [Related]
35. The effects of alphaGalCer-induced TCRValpha24 Vbeta11(+) natural killer T cells on NK cell cytotoxicity in umbilical cord blood.
Ueda Y; Hagihara M; Gansuvd B; Yu Y; Masui A; Okamoto A; Higuchi A; Tazume K; Kato S; Hotta T
Cancer Immunol Immunother; 2003 Oct; 52(10):625-31. PubMed ID: 12802518
[TBL] [Abstract][Full Text] [Related]
36. Diesel exhaust particles suppress in vivo IFN-gamma production by inhibiting cytokine effects on NK and NKT cells.
Finkelman FD; Yang M; Orekhova T; Clyne E; Bernstein J; Whitekus M; Diaz-Sanchez D; Morris SC
J Immunol; 2004 Mar; 172(6):3808-13. PubMed ID: 15004186
[TBL] [Abstract][Full Text] [Related]
37. NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo.
Stober D; Jomantaite I; Schirmbeck R; Reimann J
J Immunol; 2003 Mar; 170(5):2540-8. PubMed ID: 12594280
[TBL] [Abstract][Full Text] [Related]
38. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
Schümann J; Voyle RB; Wei BY; MacDonald HR
J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
[TBL] [Abstract][Full Text] [Related]
39. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
40. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]